RBC Capital raises Bodycote stock price target to GBP7.75 on solid outlook

RBC Capital has raised its price target for Bodycote Plc to GBP7.75 from GBP6.50, maintaining an Outperform rating, following the company's robust first-half update and positive full-year outlook. The upgrade reflects Bodycote's ahead-of-schedule restructuring and footprint rationalization efforts, stabilizing end markets with anticipated sequential improvement in the second half, and a highly attractive valuation at 14x 2025 P/E and 12x 2026 P/E for a business approaching 20% operating margins.

Analysis

RBC Capital has raised its price target on Bodycote Plc. to GBP7.75 from GBP6.50, reiterating an Outperform rating following the company's solid first-half update and full-year guidance. The upgrade is underpinned by operational execution, with Bodycote's restructuring efforts and footprint rationalization initiatives progressing ahead of expectations. Market conditions appear to be improving, as RBC notes a stabilization in end markets with an outlook for sequential improvement in the second half of the year. From a valuation perspective, RBC considers the stock 'highly attractive,' citing forward price-to-earnings ratios of 14x for 2025 and 12x for 2026 for a business that is trending towards a 20% operating margin, indicating a favorable view on both its operational efficiency and market price.

Key Decisions for Investors

• Investors should consider the positive analyst revision as a signal of improving fundamentals, driven by successful restructuring and a stabilizing market environment.
• The valuation appears attractive based on RBC's analysis, with forward P/E ratios of 14x (2025E) and 12x (2026E) for a business approaching 20% operating margins, suggesting a potentially favorable risk-reward profile.
• Monitor for confirmation of the expected sequential improvement in Bodycote's end markets in the second half, as this is a key catalyst supporting the bullish thesis.